Abstract
This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2048-2052 |
| Number of pages | 5 |
| Journal | Journal of Clinical Investigation |
| Volume | 92 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1993 |
Keywords
- Cardiorenal function
- Cgmp
- Endothelium
- Natriuretic peptide
- Vasorelaxation
ASJC Scopus subject areas
- Medicine(all)
Fingerprint Dive into the research topics of 'Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide'. Together they form a unique fingerprint.
Cite this
Wei, C. M., Kim, C. H., Miller, V. M., & Burnett, J. C. (1993). Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide. Journal of Clinical Investigation, 92(4), 2048-2052. https://doi.org/10.1172/JCI116800